Comparison MoonLake Immunotherapeutics (MLTX) with Competitors
MoonLake Immunotherapeutics (MLTX) industry is Biotechnology.
Debt-to-Equity
MLTX38.98%
Industry28.27%
Upside+37.89%
Free Cash Flow Yield
MLTX-15.76%
Industry-1.75%
Upside-14.01%
P/E
MLTX-5.57
Industry-20.52
Upside+1494.60%
P/B
MLTX6.42
Industry5.15
Upside+24.74%